initiative
-
Sandoz announces new global ‘Act4Biosimilars’ initiative
To improve patient access and increase adoption by at least 30% in 30+ countries by 2030 Sandoz announced the launch…
Read More »
To improve patient access and increase adoption by at least 30% in 30+ countries by 2030 Sandoz announced the launch…
Read More »